Recurrent cardiac arrest due to eosinophilia-related coronary vasospasm successfully treated by benralizumab.

Matthieu Groh,Marc Pineton de Chambrun,Jean-Louis Georges,Kewin Panel,Guillaume Lefèvre,Jean-Emmanuel Kahn,Colas Tcherakian, Raphaèle Convers-Domart

The journal of allergy and clinical immunology. In practice（2021）

引用 6|浏览3

暂无评分

摘要

Eosinophilia-related coronary vasospasm is a diagnosis to consider in patients with chest pain and eosinophilia. Indefinite treatment aiming to normalize absolute eosinophil counts is warranted. In this setting, benralizumab is a promising steroid-free treatment regimen and deserves further investigation.

查看译文

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要